This page shows prior authorization criteria extracted from UnitedHealthcare's published imaging guidelines. 167 matching coverage rules found for this procedure.
Abdominal Pain
Indication Code: AB-2.2
Abdominal Wall Mass
Indication Code: PEDAB-13.1
Abnormal Findings on Endoscopy/Colonoscopy
Indication Code: AB-13.3
Abnormal Uterine Bleeding
Indication Code: PEDPV-2.1
Abscess
Indication Code: PV-21.2
Adenomyosis
Indication Code: PV-4.1
Adrenal Hormone Excess/Symptomatic Adrenal Lesions
Indication Code: AB-16.2
Adrenal Tumors – Initial Work-up/Staging
Indication Code: ONC-15.10
Adrenal Tumors – Restaging/Recurrence
Indication Code: ONC-15.11
Adrenal Tumors – Surveillance
Indication Code: ONC-15.12
Adrenocortical Carcinoma
Indication Code: ONC-15.13
Amenorrhea
Indication Code: PEDPV-4.1
Anal Carcinoma – Initial Work-up/Staging
Indication Code: ONC-24.2
Anal Carcinoma – Restaging/Recurrence
Indication Code: ONC-24.3
Anal Carcinoma – Surveillance
Indication Code: ONC-24.4
Asymptomatic Hematuria
Indication Code: AB-39.2
Bilateral Wilms Tumor (BWT)
Indication Code: PEDONC-7.3
Bowel Obstruction
Indication Code: AB-20.1
Bowel Obstruction
Indication Code: PEDAB-28.1
Bronchopulmonary or Thymic Carcinoid – Initial Staging
Indication Code: ONC-15.6
Bronchopulmonary or Thymic Carcinoid – Restaging/Recurrence
Indication Code: ONC-15.7
Bronchopulmonary or Thymic Carcinoid – Surveillance
Indication Code: ONC-15.8
C-section, Cornual or Interstitial Ectopic Pregnancy
Indication Code: PV-15.3
Cancers of External Genitalia – Initial Work-Up/Staging
Indication Code: ONC-24.6
Cancers of External Genitalia – Restaging/Recurrence
Indication Code: ONC-24.7
Celiac Disease
Indication Code: AB-24.1
Cervical Cancer – Initial Work-Up/Staging
Indication Code: ONC-23.2
Cervical Cancer – Restaging/Recurrence
Indication Code: ONC-23.3
Cervical Cancer – Surveillance
Indication Code: ONC-23.4
CHF – Imaging
Indication Code: CD-9.1
Chronic Diarrhea (More than 30 Days)
Indication Code: AB-21.2
Classical Hodgkin Lymphoma
Indication Code: ONC-28.2
Clear Cell Sarcoma of the Kidney (CCSK)
Indication Code: PEDONC-7.5
Coccydynia without Neurological Features
Indication Code: SP-5.2
Colorectal Cancer – Initial Work-up/Staging
Indication Code: ONC-16.2
Colorectal Cancer – Restaging/Recurrence
Indication Code: ONC-16.3
Colorectal Cancer – Surveillance/Follow-up
Indication Code: ONC-16.4
Complex Adnexal Masses
Indication Code: PV-5.3
Congenital Mesoblastic Nephroma (CMN)
Indication Code: PEDONC-7.7
Constipation
Indication Code: AB-21.3
Constipation, Diarrhea, and Irritable Bowel Syndrome
Indication Code: PEDAB-12
Constipation, Diarrhea, and Irritable Bowel Syndrome
Indication Code: PEDAB-12
Endometriosis
Indication Code: PV-6.1
Extrathoracic Small Cell and Large Cell Neuroendocrine Tumors
Indication Code: ONC-31.8
Familial Adenomatous Polyposis (FAP) and Related Conditions
Indication Code: PEDONC-2.7
Fecal Incontinence
Indication Code: PV-22.4
Fetal MRI
Indication Code: PV-15.1
Fistula in Ano
Indication Code: PV-21.1
Fistulae
Indication Code: AB-48
Fistulae
Indication Code: AB-48
Flank Pain, Renal Stone
Indication Code: PEDAB-4
Flank Pain, Renal Stone
Indication Code: PEDAB-4
Focal Neuropathy
Indication Code: PN-2.1
Gallbladder and Biliary Tumors – Initial Work-up/Staging
Indication Code: ONC-14.6
Gallbladder and Biliary Tumors – Restaging/Recurrence
Indication Code: ONC-14.7
Gallbladder and Biliary Tumors – Surveillance/Follow-up
Indication Code: ONC-14.8
Gastric Cancer – Surveillance/Follow-up
Indication Code: ONC-14.11
Gastrointestinal Stromal Tumor (GIST)
Indication Code: ONC-12.5
Gastrointestinal/Pancreatic Neuroendocrine Cancers – Initial Work-up/Staging
Indication Code: ONC-15.3
Gastrointestinal/Pancreatic Neuroendocrine Cancers – Restaging/Recurrence
Indication Code: ONC-15.4
Gastrointestinal/Pancreatic Neuroendocrine Cancers – Surveillance
Indication Code: ONC-15.5
Gastrointestinal/Pancreatic Neuroendocrine Cancers – Suspected/Diagnosis
Indication Code: ONC-15.2
Gender Affirmation Surgery; Pelvic
Indication Code: PV-26.1
General Guidelines
Indication Code: PV-1.0
General Guidelines – Overview
Indication Code: PV-1.1
General Pain
Indication Code: MS-32.1
GI Bleeding
Indication Code: AB-22.1
Hemophagocytic Lymphohistiocytosis (HLH)
Indication Code: PEDONC-18.3
Hepatoblastoma
Indication Code: PEDONC-11.2
Hepatocellular Carcinoma (HCC) – Initial Work-up/Staging
Indication Code: ONC-14.3
Hepatocellular Carcinoma (HCC) – Restaging/Recurrence
Indication Code: ONC-14.4
Hepatocellular Carcinoma (HCC) – Surveillance/Follow-up
Indication Code: ONC-14.5
Hereditary Paraganglioma-Pheochromocytoma (HPP) Syndromes
Indication Code: PEDONC-2.13
Hydronephrosis
Indication Code: PEDAB-20
Hydronephrosis
Indication Code: PEDAB-20
Impotence/Erectile Dysfunction
Indication Code: PV-17.1
Incontinence
Indication Code: PEDPV-14.1
Indeterminate Intra-Abdominal Mass
Indication Code: AB-13.2
Inflammatory Bowel Disease, Crohn Disease, or Ulcerative Colitis
Indication Code: PEDAB-9
Inflammatory Bowel Disease, Crohn Disease, or Ulcerative Colitis
Indication Code: PEDAB-9
Inflammatory Spondylitis
Indication Code: SP-10.2
Inguinal or Femoral Hernia, or Indeterminate Groin Pain
Indication Code: AB-12.1
Intrauterine Device
Indication Code: PV-10.1
Joint Instability and Dysfunction
Indication Code: MS-30.1
Known IBD
Indication Code: AB-23.2
Leiomyoma/Uterine Fibroids
Indication Code: PV-12.1
Lower Urinary Tract Infection
Indication Code: AB-40.2
Lumbar and Lumbosacral Plexus
Indication Code: PN-5.1
LUMBAR Syndrome
Indication Code: PEDPVD-5.4
Male Pelvic Disorders
Indication Code: PV-19.1
Malignant Rhabdoid Tumor of the Kidney (MRT) and Other Extracranial Sites
Indication Code: PEDONC-7.6
MR Enterography and Enteroclysis Coding Notes
Indication Code: AB-1.4
Muscle and Tendon Injuries
Indication Code: MS-11.1
Neuroblastoma – Initial Staging
Indication Code: PEDONC-6.3
Neuroblastoma – Surveillance Imaging (Risk Group Dependent)
Indication Code: PEDONC-6.5
Neuroblastoma – Treatment Response Imaging (Risk Group Dependent)
Indication Code: PEDONC-6.4
Neuromuscular Junction Disorders
Indication Code: PN-8.4
Non-Cutaneous Indications to Suspect Occult Spinal Dysraphism
Indication Code: PEDSP-4.3
Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS)
Indication Code: PEDONC-8.3
Ocular Melanoma
Indication Code: ONC-5.9
Other Renal Cell Cancer Predisposition Syndromes
Indication Code: PEDONC-2.17
Ovarian Cancer – Initial Work-Up/Staging
Indication Code: ONC-21.3
Ovarian Cancer – Restaging/Recurrence
Indication Code: ONC-21.4
Ovarian Cancer – Surveillance
Indication Code: ONC-21.5
Ovarian Cancer – Suspected/Diagnosis
Indication Code: ONC-21.2
Pancreatic Cancer – Surveillance/Follow-up
Indication Code: ONC-13.5
Paraneoplastic Syndromes
Indication Code: ONC-30.3
Paratesticular and spermatic cord masses
Indication Code: PV-20.2
Patent Urachus
Indication Code: PEDPV-15.1
Patent Urachus
Indication Code: PV-23.1
Pediatric Aggressive Mature B-Cell Non-Hodgkin Lymphomas (NHL)
Indication Code: PEDONC-5.3
Pediatric Germ Cell Tumors
Indication Code: PEDONC-10
Pediatric Germ Cell Tumors
Indication Code: PEDONC-10
Pediatric Hepatocellular Carcinoma (HCC)
Indication Code: PEDONC-11.3
Pediatric Hodgkin Lymphoma (HL)
Indication Code: PEDONC-5.2
Pediatric Pancreatic Carcinoma
Indication Code: PEDONC-11.4
Pediatric Pelvis Imaging Modality General Considerations
Indication Code: PEDPV-1.3
Pediatric Renal Cell Carcinoma (RCC)
Indication Code: PEDONC-7.4
Pelvic Fistula
Indication Code: PV-21.3
Pelvic Inflammatory Disease
Indication Code: PV-7.1
Pelvic Inflammatory Disease (PID)
Indication Code: PEDPV-3.1
Pelvic Pain/Dyspareunia, Female
Indication Code: PV-11.1
Pelvic Prolapse
Indication Code: PV-22.3
Penis-Soft Tissue Mass
Indication Code: PV-18.1
Perirectal/Perianal Crohn's Disease
Indication Code: AB-23.3
Periurethral cysts, Skene duct cyst, Bartholin's gland cysts and Gartner’s duct cyst
Indication Code: PV-13.1
Placenta Accreta/Placenta Accreta Spectrum/Placenta Percreta
Indication Code: PV-15.2
Post-Transplant Imaging
Indication Code: PEDONC-20.2
Postoperative Pain within 60 Days Following Abdominal Surgery
Indication Code: PEDAB-11
Postoperative Pain within 60 Days Following Abdominal Surgery
Indication Code: PEDAB-11
Prostate Cancer – Follow-up On Active Surveillance
Indication Code: ONC-19.4
Prostate Cancer – Initial Work-up/Staging
Indication Code: ONC-19.2
Prostate Cancer – Restaging/Recurrence
Indication Code: ONC-19.3
Pyelonephritis
Indication Code: AB-40.1
Renal Cell Cancer (RCC) – Surveillance
Indication Code: ONC-17.4
Retained Products of Conception
Indication Code: PV-2.2
Retinoblastoma – Imaging
Indication Code: PEDONC-12.2
Retroperitoneal Fibrosis
Indication Code: AB-47.0
Right Lower Quadrant Pain
Indication Code: PEDAB-3
Right Lower Quadrant Pain
Indication Code: PEDAB-3
Sacro-Iliac (SI) Joint Pain/Sacroiliitis
Indication Code: SP-10.1
Scrotal Pathology
Indication Code: PV-20.1
Scrotal Pathology
Indication Code: PEDPV-12.1
Secondary Amenorrhea
Indication Code: PV-3.1
Small Bowel Bleeding Suspected
Indication Code: AB-22.2
Small Bowel Cancer – Initial Work-up/Staging
Indication Code: ONC-16.5
Soft Tissue Sarcomas – Initial Work-up/Staging
Indication Code: ONC-12.2
Spinal Dysraphism
Indication Code: PEDSP-4.4
Suspected Adnexal Mass – Initial Evaluation
Indication Code: PV-5.1
Suspected IBD (Crohn’s Disease or Ulcerative Colitis)
Indication Code: AB-23.1
Suspected Prostate Cancer
Indication Code: ONC-19.1
Suspected Renal/Ureteral Stone(s)
Indication Code: AB-4.1
Testicular, Ovarian and Extragonadal Germ Cell Tumors – General Considerations
Indication Code: ONC-20.0
Testicular, Ovarian and Extragonadal Germ Cell Tumors – Initial Work-Up/Staging
Indication Code: ONC-20.1
Testicular, Ovarian and Extragonadal Germ Cell Tumors – Restaging/Recurrence
Indication Code: ONC-20.2
Testicular, Ovarian and Extragonadal Germ Cell Tumors – Surveillance
Indication Code: ONC-20.3
Transitional Cell Cancer – Initial Work-up/Staging
Indication Code: ONC-18.2
Transitional Cell Cancer – Surveillance/Follow-up
Indication Code: ONC-18.4
Undescended Testis
Indication Code: PEDPV-11.1
Unilateral Wilms Tumor (UWT)
Indication Code: PEDONC-7.2
Upper Urinary Tract
Indication Code: PEDAB-5.1
Urethral Diverticula
Indication Code: PV-13.2
Uterine Anomalies
Indication Code: PV-14.1
Uterine Cancer – Initial Work-Up/Staging
Indication Code: ONC-22.2
Uterine Cancer – Restaging/Recurrence
Indication Code: ONC-22.3
Vaginal Anomalies
Indication Code: PV-14.2
Vaginal Masses
Indication Code: PV-13.3
Standard prior authorization requests are typically processed within 3–5 business days. Urgent/expedited requests may be processed within 24–72 hours when clinically necessary.
Most plans allow 30–60 days to file a first-level appeal. Expedited appeals for urgent cases are typically processed within 72 hours.
⚠ MRI uses no ionizing radiation, which is an important clinical consideration when choosing between MRI and CT.